1457458
Narasin
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 55134-13-9
Synonym(S): (4S)-4-Methylsalinomycin
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 125 MG | 1457458-125-MG | In Stock | ₹ 54,211.60 |
1457458 - 125 MG
In Stock
Quantity
1
Base Price: ₹ 54,211.60
GST (18%): ₹ 9,758.088
Total Price: ₹ 63,969.688
grade
pharmaceutical primary standard
API family
narasin
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
InChI
1S/C43H72O11/c1-12-30(35(46)27(8)34(45)28(9)36-23(4)21-24(5)37(51-36)31(13-2)39(47)48)38-25(6)22-26(7)42(52-38)18-15-32(44)43(54-42)20-19-40(11,53-43)33-16-17-41(49,14-3)29(10)50-33/h15,18,23-34,36-38,44-45,49H,12-14,16-17,19-22H2,1-11H3,(H,47,48)/t23-,24-,25-,26+,27-,28-,29-,30-,31+,32+,33+,34+,36+,37+,38-,40-,41+,42-,43-/m0/s1
InChI key
VHKXXVVRRDYCIK-CWCPJSEDSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Medchemexpress LLC HY-121410 5mg , Narasin CAS:55134-13-9 Purity:>98% | Medchemexpress LLC | ₹ 46,715.76 | |
 | Sigma Aldrich Fine Chemicals Biosciences Narasin Ready Made Solution 1 mg/ml in DMSO | 55134-13-9 | 1ML | Sigma Aldrich Fine Chemicals Biosciences | ₹ 15,721.65 | |
 | Narasin from Streptomyces auriofaciens | Sigma Aldrich | ₹ 14,289.00 - ₹ 1,25,851.45 | |
| | Narasin from Streptomyces auriofaciens | Sigma Aldrich | ₹ 14,289.00 - ₹ 1,25,851.45 | |
 | 55134-13-9 | NARASIN | A2B Chem | ₹ 21,903.36 - ₹ 49,710.36 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Narasin USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 2 Oral
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: pharmaceutical primary standard
API family: narasin
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
InChI: 1S/C43H72O11/c1-12-30(35(46)27(8)34(45)28(9)36-23(4)21-24(5)37(51-36)31(13-2)39(47)48)38-25(6)22-26(7)42(52-38)18-15-32(44)43(54-42)20-19-40(11,53-43)33-16-17-41(49,14-3)29(10)50-33/h15,18,23-34,36-38,44-45,49H,12-14,16-17,19-22H2,1-11H3,(H,47,48)/t23-,24-,25-,26+,27-,28-,29-,30-,31+,32+,33+,34+,36+,37+,38-,40-,41+,42-,43-/m0/s1
InChI key: VHKXXVVRRDYCIK-CWCPJSEDSA-N
grade:
pharmaceutical primary standard
API family:
narasin
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat
InChI:
1S/C43H72O11/c1-12-30(35(46)27(8)34(45)28(9)36-23(4)21-24(5)37(51-36)31(13-2)39(47)48)38-25(6)22-26(7)42(52-38)18-15-32(44)43(54-42)20-19-40(11,53-43)33-16-17-41(49,14-3)29(10)50-33/h15,18,23-34,36-38,44-45,49H,12-14,16-17,19-22H2,1-11H3,(H,47,48)/t23-,24-,25-,26+,27-,28-,29-,30-,31+,32+,33+,34+,36+,37+,38-,40-,41+,42-,43-/m0/s1
InChI key:
VHKXXVVRRDYCIK-CWCPJSEDSA-N
grade: pharmaceutical primary standard
API family: natamycin
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
InChI: 1S/C33H47NO13/c1-18-10-8-6-4-3-5-7-9-11-21(45-32-30(39)28(34)29(38)19(2)44-32)15-25-27(31(40)41)22(36)17-33(42,47-25)16-20(35)14-24-23(46-24)12-13-26(37)43-18/h3-9,11-13,18-25,27-30,32,35-36,38-39,42H,10,14-17,34H2,1-2H3,(H,40,41)/b4-3+,7-5+,8-6+,11-9+,13-12+/t18-,19-,20+,21+,22+,23-,24-,25+,27-,28+,29-,30+,32+,33-/m1/s1
InChI key: NCXMLFZGDNKEPB-FFPOYIOWSA-N
grade:
pharmaceutical primary standard
API family:
natamycin
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat
InChI:
1S/C33H47NO13/c1-18-10-8-6-4-3-5-7-9-11-21(45-32-30(39)28(34)29(38)19(2)44-32)15-25-27(31(40)41)22(36)17-33(42,47-25)16-20(35)14-24-23(46-24)12-13-26(37)43-18/h3-9,11-13,18-25,27-30,32,35-36,38-39,42H,10,14-17,34H2,1-2H3,(H,40,41)/b4-3+,7-5+,8-6+,11-9+,13-12+/t18-,19-,20+,21+,22+,23-,24-,25+,27-,28+,29-,30+,32+,33-/m1/s1
InChI key:
NCXMLFZGDNKEPB-FFPOYIOWSA-N
grade: __
API family: __
manufacturer/tradename: __
application(s): __
format: __
InChI: __
InChI key: __
grade:
__
API family:
__
manufacturer/tradename:
__
application(s):
__
format:
__
InChI:
__
InChI key:
__
grade: pharmaceutical primary standard
API family: nateglinide
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
InChI: 1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1
InChI key: OELFLUMRDSZNSF-BRWVUGGUSA-N
grade:
pharmaceutical primary standard
API family:
nateglinide
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat
InChI:
1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1
InChI key:
OELFLUMRDSZNSF-BRWVUGGUSA-N